Total turnover of Kaluga pharmaceutical cluster has amounted to 27,5 bln rubles

| By | Drug Manufacturing, Pharmclusters

Kaluga pharmaceutical cluster has demonstrated the best growth rate in recent years under current conditions in the region, announced Dmitriy Razumovskiy, Head of the Regional Ministry for economic development at its end-of-year session. Industrial production output as a whole amounted to 108.6%, and the increase of pharmaceutical products – 137.3%.

“The volume of medicinal drugs produced in the region in 2016 has amounted to more than 12 bln rubles, that is 2.5 times higher than the 2015 level. Meanwhile, the total turnover of all cluster enterprises has reached 27.5 bln rubles”, — said Razumovskiy.

Dmirtiy Razumovskiy also mentioned that in 2016 the Ministry for Economic Development of Russian Federation recognized Kaluga pharmaceutical cluster as a leader of investment appeal at the global level.